After Months of Haggling, Sanofi Getting Closer to Buying Genzyme

摘要

With Sanofi-Aventis nearing a deal to purchase Genzyme, an acquisition would bolster the French drugmaker’s pipeline, especially in biologics, and could soften the blow from a critical marketing exclusivity cliff for several of its key products.